Tokyo Tape
Sign in
← J Frontier

Annual report

2934.TEDINET S100SX2D
Period2022-06-01 → 2023-05-31
Filed2024-02-21
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed

Amends S100RRVE. Amended by S100SXUN (2024-02-21).

Key figures · 116
MetricValuePeriodScopeSource row
Revenue¥16.8bn2022-06-01 → 2023-05-31Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales
Operating income−¥1.8bn2022-06-01 → 2023-05-31Cons.Operating income
Operating income¥731m2021-06-01 → 2022-05-31Cons.Operating income
Ordinary income−¥1.8bn2022-06-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥712m2021-06-01 → 2022-05-31Cons.Ordinary income
Profit before tax−¥1.8bn2022-06-01 → 2023-05-31Cons.Income before income taxes
Profit before tax¥700m2021-06-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss
Net income¥400m2021-06-01 → 2022-05-31Cons.Profit loss
Total assets¥7.2bnat 2023-05-31Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total liabilities¥4.5bnat 2023-05-31Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥2.7bnat 2023-05-31Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥1.3bnat 2021-05-31dCons.Net assets
Cash and deposits¥1.6bnat 2023-05-31Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥1.6bnat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥1.8bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥367m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.5bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-410.62022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥525.78at 2023-05-31Cons.Net assets per share (5-year summary)
Net assets per share¥907.43at 2022-05-31Cons.Net assets per share (5-year summary)
Equity ratio34.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
ROE9.7%2021-06-01 → 2022-05-31Cons.Rate of return on equity (5-year summary)
Employees255at 2023-05-31Cons.Number of employees
Employees278at 2022-05-31Cons.Number of employees
Revenue¥9.4bn2022-06-01 → 2023-05-31StandaloneNet sales
Revenue¥9.3bn2021-06-01 → 2022-05-31StandaloneNet sales
Revenue¥8.5bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Revenue¥7.1bn2019-06-01 → 2020-05-31dStandaloneNet sales (5-year summary)
Revenue¥6.1bn2018-06-01 → 2019-05-31dStandaloneNet sales (5-year summary)
Operating income−¥1.7bn2022-06-01 → 2023-05-31StandaloneOperating income
Operating income¥751m2021-06-01 → 2022-05-31StandaloneOperating income
Ordinary income−¥1.7bn2022-06-01 → 2023-05-31StandaloneOrdinary income
Ordinary income¥724m2021-06-01 → 2022-05-31StandaloneOrdinary income
Ordinary income¥679m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥174m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥367m2018-06-01 → 2019-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.7bn2022-06-01 → 2023-05-31StandaloneIncome before income taxes
Profit before tax¥723m2021-06-01 → 2022-05-31StandaloneIncome before income taxes
Net income−¥1.7bn2022-06-01 → 2023-05-31StandaloneProfit loss
Net income¥450m2021-06-01 → 2022-05-31StandaloneProfit loss
Net income¥425m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Net income¥96m2019-06-01 → 2020-05-31dStandaloneNet income loss (5-year summary)
Net income¥6m2018-06-01 → 2019-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.8bnat 2023-05-31StandaloneAssets
Total assets¥5.3bnat 2022-05-31StandaloneAssets
Total assets¥2.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total assets¥2.0bnat 2020-05-31dStandaloneTotal assets (5-year summary)
Total assets¥1.9bnat 2019-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-05-31StandaloneLiabilities
Total liabilities¥1.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥2.8bnat 2023-05-31StandaloneNet assets
Net assets / equity¥4.2bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets
Net assets / equity¥843mat 2020-05-31dStandaloneNet assets (5-year summary)
Net assets / equity¥746mat 2019-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥814mat 2023-05-31StandaloneCash and deposits
Cash and deposits¥2.4bnat 2022-05-31StandaloneCash and deposits
Cash & equivalents¥1.6bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥902mat 2020-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥948mat 2019-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥831m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥218m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥14m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥165m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥63m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥94m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥99m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥130m2018-06-01 → 2019-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-357.082022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥101.912021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥110.752020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.122019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.62018-06-01 → 2019-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥97.452021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥589.16at 2023-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥918.35at 2022-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥329.99at 2021-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥219.25at 2020-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥194.13at 2019-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio47.4%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio48.8%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio41.5%at 2020-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio39.0%at 2019-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE-47.5%2022-06-01 → 2023-05-31StandaloneRate of return on equity (5-year summary)
ROE16.5%2021-06-01 → 2022-05-31StandaloneRate of return on equity (5-year summary)
ROE40.3%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
ROE12.2%2019-06-01 → 2020-05-31dStandaloneRate of return on equity (5-year summary)
ROE0.8%2018-06-01 → 2019-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,892,098at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,757,616at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2020-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,918,500at 2019-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees49at 2023-05-31StandaloneNumber of employees
Employees54at 2022-05-31StandaloneNumber of employees
Employees46at 2021-05-31dStandaloneNumber of employees
Employees47at 2020-05-31dStandaloneNumber of employees
Employees42at 2019-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 71
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-06-01 → 2023-05-31¥2m
Reconciling Itemsreconcilingdepreciation2022-06-01 → 2023-05-31¥765,000
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-05-31−¥186m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-05-31−¥186m
Reconciling Itemsreconcilingsegment assetsat 2023-05-31¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-05-31−¥729m
Healthcare Marketing Businessreportable segmentcapex2022-06-01 → 2023-05-31¥4m
Healthcare Marketing Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥5m
Healthcare Marketing Businessreportable segmentemployeesat 2023-05-3148 pure
Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥5.2bn
Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥5.1bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-05-31¥185m
Healthcare Marketing Businessreportable segmentsegment assetsat 2023-05-31¥1.1bn
Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-05-31¥39m
Healthcare Sales Businessreportable segmentcapex2022-06-01 → 2023-05-31¥1.1bn
Healthcare Sales Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥4m
Healthcare Sales Businessreportable segmentemployeesat 2023-05-3148 pure
Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥4.1bn
Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥4.1bn
Healthcare Sales Businessreportable segmentsegment assetsat 2023-05-31¥2.4bn
Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥28m
Medical Care Sales Businessreportable segmentcapex2022-06-01 → 2023-05-31¥288m
Medical Care Sales Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥14m
Medical Care Sales Businessreportable segmentemployeesat 2023-05-31144 pure
Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥7.7bn
Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥7.7bn
Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-05-31¥564,000
Medical Care Sales Businessreportable segmentsegment assetsat 2023-05-31¥2.4bn
Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥1.1bn
—segment totalemployeesat 2023-05-31255 pure
Total Of Reportable Segments And Otherssegment totalcapex2022-06-01 → 2023-05-31¥1.4bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-06-01 → 2023-05-31¥23m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-05-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-05-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-05-31¥186m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-05-31¥5.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-05-31−¥1.1bn
Reconciling Itemsreconcilingcapex2021-06-01 → 2022-05-31¥5m
Reconciling Itemsreconcilingdepreciation2021-06-01 → 2022-05-31¥5m
Reconciling Itemsreconcilingrevenue2021-06-01 → 2022-05-31−¥54m
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2022-05-31−¥54m
Reconciling Itemsreconcilingsegment assetsat 2022-05-31¥2.7bn
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-05-31−¥425m
Healthcare Marketing Businessreportable segmentcapex2021-06-01 → 2022-05-31¥362m
Healthcare Marketing Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥2m
Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥3.9bn
Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥3.8bn
Healthcare Marketing Businessreportable segmentrevenue intersegment2021-06-01 → 2022-05-31¥54m
Healthcare Marketing Businessreportable segmentsegment assetsat 2022-05-31¥1.3bn
Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥37m
Healthcare Sales Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥703,000
Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥3.0bn
Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥3.0bn
Healthcare Sales Businessreportable segmentsegment assetsat 2022-05-31¥251m
Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥779m
Medical Care Sales Businessreportable segmentcapex2021-06-01 → 2022-05-31¥588m
Medical Care Sales Businessreportable segmentdepreciation2021-06-01 → 2022-05-31¥3m
Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2022-05-31¥5.0bn
Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2022-05-31¥5.0bn
Medical Care Sales Businessreportable segmentsegment assetsat 2022-05-31¥1.9bn
Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2022-05-31¥339m
Total Of Reportable Segments And Otherssegment totalcapex2021-06-01 → 2022-05-31¥950m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-06-01 → 2022-05-31¥5m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-05-31¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-05-31¥11.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-06-01 → 2022-05-31¥54m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-05-31¥3.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-05-31¥1.2bn
Healthcare Marketing Businessreportable segmentemployeesat 2023-05-3110 pure
Healthcare Sales Businessreportable segmentemployeesat 2023-05-3119 pure
Medical Care Sales Businessreportable segmentemployeesat 2023-05-318 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,468
ItemContextValueUnit
Extraordinary lossPrior1YearDuration11302000JPY
Extraordinary lossCurrentYearDuration5657000JPY
Income before income taxesPrior1YearDuration700429000JPY
Income before income taxesCurrentYearDuration-1846856000JPY
Income taxes currentPrior1YearDuration283608000JPY
Income taxes currentCurrentYearDuration100577000JPY
Income taxes deferredPrior1YearDuration16536000JPY
Income taxes deferredCurrentYearDuration-80010000JPY
Income taxesPrior1YearDuration300144000JPY
Income taxesCurrentYearDuration20567000JPY
Profit lossPrior1YearDuration400284000JPY
Profit lossCurrentYearDuration-1867423000JPY
Profit loss attributable to non controlling interestsPrior1YearDuration-234000JPY
Profit loss attributable to non controlling interestsCurrentYearDuration32495000JPY
Profit loss attributable to owners of parentPrior1YearDuration400519000JPY
Profit loss attributable to owners of parentCurrentYearDuration-1899919000JPY
Profit lossPrior1YearDuration400284000JPY
Profit lossCurrentYearDuration-1867423000JPY
Comprehensive incomePrior1YearDuration400284000JPY
Comprehensive incomeCurrentYearDuration-1867423000JPY
Comprehensive income attributable to owners of the parentPrior1YearDuration400519000JPY
Comprehensive income attributable to owners of the parentCurrentYearDuration-1899919000JPY
Comprehensive income attributable to non controlling interestsPrior1YearDuration-234000JPY
Comprehensive income attributable to non controlling interestsCurrentYearDuration32495000JPY
Net assetsPrior2YearInstant_CapitalStockMember26377000JPY
Net assetsPrior2YearInstant_CapitalSurplusMember9377000JPY
Net assetsPrior2YearInstant_RetainedEarningsMember1230435000JPY
Net assetsPrior2YearInstant_TreasuryStockMember－JPY
Net assetsPrior2YearInstant_ShareholdersEquityMember1266190000JPY
Issuance of new sharesPrior1YearDuration_CapitalStockMember1445550000JPY
Issuance of new sharesPrior1YearDuration_CapitalSurplusMember1445550000JPY
Issuance of new sharesPrior1YearDuration_ShareholdersEquityMember2891100000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_CapitalStockMember15051000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_CapitalSurplusMember15051000JPY
Issuance of new sharesexercise of subscription rights to sharesPrior1YearDuration_ShareholdersEquityMember30102000JPY
Transfer to other capital surplus from capital stockPrior1YearDuration_ShareholdersEquityMember－JPY
Profit loss attributable to owners of parentPrior1YearDuration_RetainedEarningsMember400519000JPY
Profit loss attributable to owners of parentPrior1YearDuration_ShareholdersEquityMember400519000JPY
Purchase of treasury stockPrior1YearDuration_TreasuryStockMember-452200000JPY
Purchase of treasury stockPrior1YearDuration_ShareholdersEquityMember-452200000JPY
Total changes of items during the periodPrior1YearDuration_CapitalStockMember1460601000JPY
Total changes of items during the periodPrior1YearDuration_CapitalSurplusMember1460601000JPY
Total changes of items during the periodPrior1YearDuration_RetainedEarningsMember400519000JPY
Total changes of items during the periodPrior1YearDuration_TreasuryStockMember-452200000JPY
Total changes of items during the periodPrior1YearDuration_ShareholdersEquityMember2869521000JPY
Net assetsPrior1YearInstant_CapitalStockMember1486978000JPY
Net assetsPrior1YearInstant_CapitalSurplusMember1469978000JPY
Net assetsPrior1YearInstant_RetainedEarningsMember1630954000JPY
Net assetsPrior1YearInstant_TreasuryStockMember-452200000JPY
Net assetsPrior1YearInstant_ShareholdersEquityMember4135711000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2023-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2021-05-31pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2023-05-31pass
statement vs summary · revenueconsolidated 2021-06-01/2022-05-31pass
statement vs summary · revenueconsolidated 2022-06-01/2023-05-31pass
statement vs summary · revenuenon_consolidated 2021-06-01/2022-05-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass